Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Alimetry

Explore full profile

Alimetry is a health technology startup based in Auckland, New Zealand

Auckland, New ZealandFounded 2019Health Tech & Medtech
Valuation $50–100M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Alimetry and the history behind them.

About Alimetry

Gastric Alimetry is a pioneering medical technology company that specializes in diagnosing and evaluating upper gastrointestinal (GI) disorders. The company has developed a cutting-edge medical device known as the Gastric Alimetry system, which performs Body Surface Gastric Mapping. This system records, stores, views, and processes gastric electrophysiology data to aid clinicians in diagnosing various gastric disorders.

Read full description

The primary clients of Gastric Alimetry are healthcare providers, including clinicians and gastroenterologists, who require advanced tools to diagnose patients with chronic gastric symptoms. These symptoms often remain elusive with traditional diagnostic methods. The company operates in the healthcare market, specifically focusing on gastrointestinal health within the United States, United Kingdom, and New Zealand.

Gastric Alimetry's business model revolves around the sale and utilization of its medical device and associated software. The company generates revenue by selling the Gastric Alimetry system to healthcare facilities and providing ongoing support and updates. Additionally, the company offers a companion app that allows patients to log their symptoms, adding another layer of data for clinicians to analyze.

The Gastric Alimetry system provides a comprehensive report that offers objective, data-driven insights into gastric function, motility, and electrophysiology. This report helps clinicians determine whether a patient's gastric function is normal or abnormal using validated normative values. It also aids in distinguishing the root causes of chronic gastric symptoms through spectral and symptom-based phenotyping.

In summary, Gastric Alimetry is revolutionizing the way clinicians diagnose and treat upper GI disorders by providing a clear, data-driven pathway for treatment. This innovative approach not only enhances diagnostic accuracy but also improves patient outcomes.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2019
Headquarters
Auckland, New Zealand
Employees
69
Open positions
None listed
Dealroom signal
83.5/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Gastroenterology, Health Diagnostics, Spinout, NZ tech startup, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Oct 2024 $18M $72M Olympus Innovation Ventures · Icehouse Ventures · Global From Day One · AGA Ventures ↗
SERIES A✓Equity / VC Mar 2022 $11M $42M IP Group · Movac · Auckland UniServices · K1W1 ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Alimetry website traffic

Latest recorded traffic for Alimetry is 5.5K monthly website visits, up 129.2% over the last three months. Alimetry's team declined 1.4% over the past year.

Latest monthly visits5.5K 3-month web change+129.2% 1-year team growth-1.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • IP Group Australia

Series A9 investors entered at this stage

  • IP Group
  • Movac
  • Auckland UniServices
  • K1W1
  • Matu
  • Global From Day One
  • Olympus Innovation Ventures
  • Icehouse Ventures
  • AGA Ventures

Other known investors1 additional known investor

  • The University of Auckland
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇳🇿 New Zealand73.3%
🇺🇸 United States16.7%
🇦🇺 Australia3.3%
🇬🇧 United Kingdom3.3%
🇨🇦 Canada1.7%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Alimetry on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Alimetry’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.